Clinical Scorecard: Imaging Indicators of Glymphatic Dysfunction in Tuberculous Meningitis: Links to Cerebrospinal Fluid Proteins and Cognitive Decline
At a Glance
Category
Detail
Condition
Key Mechanisms
Glymphatic dysfunction linked to cognitive decline and cerebrospinal fluid (CSF) protein alterations; specify the nature of these alterations.
Target Population
Care Setting
Key Highlights
4
Guideline-Based Recommendations
Diagnosis
Management
Consider the role of glymphatic dysfunction in cognitive decline when planning treatment for TBM, including specific strategies.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Imaging biomarkers such as ALPS and CPV may inform treatment strategies targeting cognitive dysfunction.
Clinical Best Practices
Incorporate fMRI assessments to evaluate glymphatic function in TBM patients.
Use cognitive assessments alongside imaging to provide a comprehensive evaluation of patient status.
Recognize the importance of CSF dynamics in understanding cognitive outcomes in TBM.
Include follow-up assessments to track cognitive changes over time.
